master's thesis
ZNAČAJKE LIJEČENJA INTERFERONOM BETA 1a i 1b U BOLESNIKA S MULTIPLOM SKLEROZOM

Gogić, Tina
University of Split
School of Medicine
Neurology

Cite this document

Gogić, T. (2017). ZNAČAJKE LIJEČENJA INTERFERONOM BETA 1a i 1b U BOLESNIKA S MULTIPLOM SKLEROZOM (Master's thesis). Retrieved from https://urn.nsk.hr/urn:nbn:hr:171:005204

Gogić, Tina. "ZNAČAJKE LIJEČENJA INTERFERONOM BETA 1a i 1b U BOLESNIKA S MULTIPLOM SKLEROZOM." Master's thesis, University of Split, School of Medicine, 2017. https://urn.nsk.hr/urn:nbn:hr:171:005204

Gogić, Tina. "ZNAČAJKE LIJEČENJA INTERFERONOM BETA 1a i 1b U BOLESNIKA S MULTIPLOM SKLEROZOM." Master's thesis, University of Split, School of Medicine, 2017. https://urn.nsk.hr/urn:nbn:hr:171:005204

Gogić, T. (2017). 'ZNAČAJKE LIJEČENJA INTERFERONOM BETA 1a i 1b U BOLESNIKA S MULTIPLOM SKLEROZOM', Master's thesis, University of Split, School of Medicine, accessed 02 May 2022, https://urn.nsk.hr/urn:nbn:hr:171:005204

Gogić T. ZNAČAJKE LIJEČENJA INTERFERONOM BETA 1a i 1b U BOLESNIKA S MULTIPLOM SKLEROZOM [Master's thesis]. Split: University of Split, School of Medicine; 2017 [cited 2022 May 02] Available at: https://urn.nsk.hr/urn:nbn:hr:171:005204

T. Gogić, "ZNAČAJKE LIJEČENJA INTERFERONOM BETA 1a i 1b U BOLESNIKA S MULTIPLOM SKLEROZOM", Master's thesis, University of Split, School of Medicine, Split, 2017. Available at: https://urn.nsk.hr/urn:nbn:hr:171:005204

Please login to the repository to save this object to your list.